4//SEC Filing
HYPERION THERAPEUTICS INC 4
Accession 0001437749-15-009010
CIK 0001386858operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:35 PM ET
Size
13.2 KB
Accession
0001437749-15-009010
Insider Transaction Report
Form 4
Nash Christine A
SVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-05-01$1.28/sh+16,157$20,681→ 53,160 total - Exercise/Conversion
Common Stock
2015-05-01$4.08/sh+12,709$51,853→ 65,869 total - Exercise/Conversion
Common Stock
2015-05-01$7.31/sh+30,221$220,916→ 96,090 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-05-01−30,221→ 6,881 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (30,221 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-05-01−16,157→ 0 totalExercise: $1.28Exp: 2020-04-14→ Common Stock (16,157 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-05-01−12,709→ 0 totalExercise: $4.08Exp: 2021-04-14→ Common Stock (12,709 underlying)
Footnotes (1)
- [F1]This option was vested and exercisable on date of exercise.
Documents
Issuer
HYPERION THERAPEUTICS INC
CIK 0001386858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001386858
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:35 PM ET
- Size
- 13.2 KB